TrialHeart (British Cardiac Society)2007

Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study.

Andrew Briggs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.